SC

Suresh Chandumal Vazirani

Director Director DIN 07956933
DIN 07956933 First appointment Nov 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Chandumal Vazirani

Data last updated:

Suresh Chandumal Vazirani was a Director at Hemmo Pharmaceuticals Private Limited (2019–2021) and Director at Elemar Lifesciences Private Limited (from 2017). The companies operate in Pharma.

DIN 07956933
Primary Designation Director
Industry Pharma
First Appointment 01 Nov 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jun 20191979₹133 Cr (FY 2021)Amalgamated
Elemar Lifesciences Private Limited U24304MH2017PTC301378
Director01 Nov 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elemar Lifesciences Private Limited
Hemmo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suresh Chandumal Vazirani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Chandumal Vazirani

Suresh Chandumal Vazirani was first appointed on 01 Nov 2017 as Director at Elemar Lifesciences Private Limited. The most recent appointment on record is 19 Jun 2019 at Hemmo Pharmaceuticals Private Limited.

Suresh Chandumal Vazirani held 2 earlier board appointments: Hemmo Pharmaceuticals Private Limited (Director, 19 Jun 2019 to 22 Jun 2021); Elemar Lifesciences Private Limited (Director, from 01 Nov 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available